CTLA4 and neoplasm: Radiation can activate a type 1 interferon (IFN1) response in tumor cells, and in preclinical studies this has been shown to be critical to the role of radiation in activating an anti-tumor immune response in combination with immune checkpoint inhibition (ICI, eg. anti-CTLA-4, anti-PD-1/PD-L1) 1-10.